menu
    • menu

    Company profile for Parabilis Medicines

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Parabilis Medicines, formerly Fog Pharmaceuticals, is a clinical-stage biopharmaceutical company focused on developing transformative therapies that address the limitations of existing treatments and aim to make a meaningful difference in patients’ lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Parabilis MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge Discovery Park 30 Acorn Park Drive, Cambridge, MA 02140
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://parabilismed.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/parabilis-medicines/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Parabilis Medicines Showcases Positive Early Data
    Parabilis Medicines Showcases Positive Early Data

    21 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251121107097/en/Parabilis-Medicines-Highlights-Promising-Preliminary-Clinical-Results-in-Patients-with-Adamantinomatous-Craniopharyngioma-from-Ongoing-FOG-001-Clinical-Trial-at-SNO-2025

    BUSINESSWIRE
    21 Nov 2025
    Share Share
    Parabilis Medicines Secures FDA Fast Track for FOG-001
    Parabilis Medicines Secures FDA Fast Track for FOG-001

    12 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251112954263/en/Parabilis-Medicines-Receives-FDA-Fast-Track-Designation-for-FOG-001-the-First-and-Only-Direct-Inhibitor-of-the--cateninTCF-Interaction-for-the-Treatment-of-Desmoid-Tumors

    BUSINESSWIRE
    12 Nov 2025
    Share Share
    Parabilis Shows Helicon Peptide Data at AACR-NCI-EORTC 2025
    Parabilis Shows Helicon Peptide Data at AACR-NCI-EORTC 2025

    30 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251024425471/en/CORRECTING-and-REPLACING-Parabilis-Medicines-Presents-Clinical-and-Preclinical-Data-Demonstrating-Broad-Potential-of-Helicon-Peptides-at-AACR-NCI-EORTC-2025

    BUSINESSWIRE
    30 Oct 2025
    Share Share
    Parabilis Presents Helicon Peptide Data at AACR-NCI-EORTC
    Parabilis Presents Helicon Peptide Data at AACR-NCI-EORTC

    24 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251024425471/en/Parabilis-Medicines-Presents-Clinical-and-Preclinical-Data-Demonstrating-Broad-Potential-of-Helicon-Peptides-at-AACR-NCI-EORTC-2025

    BUSINESSWIRE
    24 Oct 2025
    Share Share
    Parabilis Shows First-Ever Drugging of Cancer Driver FOG-001
    Parabilis Shows First-Ever Drugging of Cancer Driver FOG-001

    17 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251017729691/en/Parabilis-Medicines-Presents-Clinical-Data-Demonstrating-First-Ever-Drugging-of-Key-Cancer-Driver-with-FOG-001

    BUSINESSWIRE
    17 Oct 2025
    Share Share
    Parabilis Medicines Names Fawzi Benzaghou, M.D., Chief Medical
    Parabilis Medicines Names Fawzi Benzaghou, M.D., Chief Medical

    03 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-03/parabilis-medicines-appoints-fawzi-benzaghou-md-as-chief-medical-officer

    PHARMAWEB
    03 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search